Min.Order : 1 Pieces Quick Quotation >
Conpany Profile
Product Details
Product Information
| CAS NO. | 171099-57-3 |  |
| Product Name | Oritavancin | |
| Synonyms | LY 333328 | |
| Formula | C86H97Cl3N10O26 | |
| Molecular Weight | 1793.12 | |
| Spec / Purity | 98%min | |
| Supply Capacity | ||
| Details | Oritavancin (LY333328/Orbactiv) is a novel semisynthetic glycopeptide antibiotic being developed for the treatment of serious Gram-positive bacterial infections. In December 2008, the US FDA declined to approve it without additional studies, and an EU application was withdrawn. In 2009, the development rights were acquired by The Medicines Company, which has completed clinical trials and submitted a new drug application to the FDA in February 2014. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections in the United States. Its chemical structure is similar to vancomycin. It is a lipoglycopeptide. | |
Recommend Product
Privacy Policy -Terms of Use
Greater stability and upgraded communication tools
Home
Inquiries
RFQ
Your Request
My Favorites
Order